Original Research

Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma

Zhou L, Lin J, Wu G, Chen J, Huang X, Zhang S

Drug Design, Development and Therapy 2020, 14:1257-1262

Published Date: 30 March 2020